Monique Lewis

Sr Executive Immunology Specialist @Johnson & Johnson Innovative Medicine

Launched and Market Simponi Aria(Golimulab) for Rheumatoid Arthritis, Psoriatic ArthritisLaunched and Market Tremfiya(Guselkumab) for PsoriasisLaunched and Market STELARA® (ustekinumab, IV & Subq) for Crohn’s Disease with a misc. J-Code.• Market Biologic infusion REMICADE® (infliximab, IV), STELARA® (ustekinumab, IV & Subq), and Simponi® (golimumab, Subq) to Gastroenterologists, Rheumatologists, and Dermatologists at teaching institutions in the Brooklyn, Queens, Bronx, Long Island area• Provide a clear understanding of billing with a misc. J-Code, products access, fulfillment and reimbursement resources to “buy and bill” accounts, infusion centers, pharmacies and hospital accounts. • Placed Stelara on Formulary at Winthrop and Stony Brook Hospital within 2 months of launch date.• Partner with contracted specialty pharmacy providers and a central reimbursement center (HUB) to coordinate and ensure patient access and support to our products.